2m 2m 2m 2m 2m 2m - S&P 600$1,709.07
2m
Merck (MRK)
NYSE
$145.52-$2.24 (-1.52%)
Price as of Nov 16, 2026 7:26 PM EST- $364.3BMarket Cap
- 63.69%1-Year Change
- Drug Manufacturers - GeneralIndustry
Merck (MRK)
$145.52-$2.24 (-1.52%)
MRK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $147.76 | ||
Change | +$0.81 (+0.55%) | ||
Open | $147.31 | ||
High | $147.99 | ||
Low | $145.24 | ||
Previous Close | $146.95 | ||
Volume | 6,507,620 | ||
30-Day Average Volume | 9,923,292 | ||
1-Week Change | 0.70% | ||
1-Month Change | 4.07% | ||
1-Year Change | 63.69% | ||
3-Year Change | 58.01% | ||
5-Year Change | 104.97% | ||
Fundamentals | |||
Shares Outstanding | 2.5B | ||
Total Assets | $132.8B | ||
Market Cap | $364.3B | ||
Enterprise Value | $408.5B | ||
Period: QTR TTM FY | |||
Revenue | $18.1B | ||
Net Income | $5.1B | ||
Free Cash Flow | $5.5B | ||
EBIT | $5.6B | ||
EBITDA | $6.3B | ||
Net Working Capital | $10.1B | ||
EPS | $2.04 | ||
Enterprise Value/EBITDA | 65 | ||
Enterprise Value/Revenue | 23 | ||
P/B | 8 | ||
P/E | 72 | ||
PEG | 0 | ||
Price/Free Cash Flow | 66 | ||
Price/Operating Cash Flow | 56 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.30% | ||
Trailing Annual Dividend Yield | 2.30% | ||
Ex-Dividend Date | 09/15/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield